Validation of Revised American Joint Committee on cancer staging for gallbladder cancer based on a single institution experience

Christina Y. Koh, Aram N. Demirjian, Wen Pin Chen, Christine E. McLaren, David K. Imagawa

Research output: Contribution to journalArticle

Abstract

Gallbladder cancer is a rare malignancy, which often goes undiagnosed until advanced stages of disease and is associated with poor prognosis. The only potentially curative treatment is surgical resection. This retrospective study aims to investigate the validity of the revised 7th edition American Joint Committee on Cancer staging criteria and determine prognostic factors. Forty-two patients with confirmed gallbladder cancer who underwent attempted curative resection from 1999 to 2012 at the University of California, Irvine Medical Center were reviewed. Survival probability was determined using the Kaplan-Meier method. Ten patients underwent laparoscopy, were deemed unresectable, and no further surgical intervention was performed. R0 surgical resection, which included radical portal lymphadenectomy, liver segment IVb/Vresection, with or without bile duct resection, was performed in the remaining 32 patients. N2 nodes were resected if positive on frozen section. Overall survival probability for Stage I to II patients was 100 per cent. Overall survival probability for Stage III patients was 80 per cent (95% confidence interval [CI], 61 to 99%) and 39.3 per cent (95% CI, 28 to 78%) for Stage IV patients. This study demonstrates that 7th edition clinical stage, T stage, and liver involvement are statistically significant predictors of prognosis. These data also demonstrate a benefit to extended resection in patients even with Stage III and IV disease.

Original languageEnglish (US)
Pages (from-to)1045-1049
Number of pages5
JournalAmerican Surgeon
Volume79
Issue number10
StatePublished - Oct 2013
Externally publishedYes

Fingerprint

Gallbladder Neoplasms
Neoplasm Staging
Survival
Confidence Intervals
Liver
Frozen Sections
Bile Ducts
Lymph Node Excision
Laparoscopy
Retrospective Studies

ASJC Scopus subject areas

  • Surgery

Cite this

Koh, C. Y., Demirjian, A. N., Chen, W. P., McLaren, C. E., & Imagawa, D. K. (2013). Validation of Revised American Joint Committee on cancer staging for gallbladder cancer based on a single institution experience. American Surgeon, 79(10), 1045-1049.

Validation of Revised American Joint Committee on cancer staging for gallbladder cancer based on a single institution experience. / Koh, Christina Y.; Demirjian, Aram N.; Chen, Wen Pin; McLaren, Christine E.; Imagawa, David K.

In: American Surgeon, Vol. 79, No. 10, 10.2013, p. 1045-1049.

Research output: Contribution to journalArticle

Koh, CY, Demirjian, AN, Chen, WP, McLaren, CE & Imagawa, DK 2013, 'Validation of Revised American Joint Committee on cancer staging for gallbladder cancer based on a single institution experience', American Surgeon, vol. 79, no. 10, pp. 1045-1049.
Koh, Christina Y. ; Demirjian, Aram N. ; Chen, Wen Pin ; McLaren, Christine E. ; Imagawa, David K. / Validation of Revised American Joint Committee on cancer staging for gallbladder cancer based on a single institution experience. In: American Surgeon. 2013 ; Vol. 79, No. 10. pp. 1045-1049.
@article{f38b13f6b45049f4ad42d287921c1b37,
title = "Validation of Revised American Joint Committee on cancer staging for gallbladder cancer based on a single institution experience",
abstract = "Gallbladder cancer is a rare malignancy, which often goes undiagnosed until advanced stages of disease and is associated with poor prognosis. The only potentially curative treatment is surgical resection. This retrospective study aims to investigate the validity of the revised 7th edition American Joint Committee on Cancer staging criteria and determine prognostic factors. Forty-two patients with confirmed gallbladder cancer who underwent attempted curative resection from 1999 to 2012 at the University of California, Irvine Medical Center were reviewed. Survival probability was determined using the Kaplan-Meier method. Ten patients underwent laparoscopy, were deemed unresectable, and no further surgical intervention was performed. R0 surgical resection, which included radical portal lymphadenectomy, liver segment IVb/Vresection, with or without bile duct resection, was performed in the remaining 32 patients. N2 nodes were resected if positive on frozen section. Overall survival probability for Stage I to II patients was 100 per cent. Overall survival probability for Stage III patients was 80 per cent (95{\%} confidence interval [CI], 61 to 99{\%}) and 39.3 per cent (95{\%} CI, 28 to 78{\%}) for Stage IV patients. This study demonstrates that 7th edition clinical stage, T stage, and liver involvement are statistically significant predictors of prognosis. These data also demonstrate a benefit to extended resection in patients even with Stage III and IV disease.",
author = "Koh, {Christina Y.} and Demirjian, {Aram N.} and Chen, {Wen Pin} and McLaren, {Christine E.} and Imagawa, {David K.}",
year = "2013",
month = "10",
language = "English (US)",
volume = "79",
pages = "1045--1049",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "10",

}

TY - JOUR

T1 - Validation of Revised American Joint Committee on cancer staging for gallbladder cancer based on a single institution experience

AU - Koh, Christina Y.

AU - Demirjian, Aram N.

AU - Chen, Wen Pin

AU - McLaren, Christine E.

AU - Imagawa, David K.

PY - 2013/10

Y1 - 2013/10

N2 - Gallbladder cancer is a rare malignancy, which often goes undiagnosed until advanced stages of disease and is associated with poor prognosis. The only potentially curative treatment is surgical resection. This retrospective study aims to investigate the validity of the revised 7th edition American Joint Committee on Cancer staging criteria and determine prognostic factors. Forty-two patients with confirmed gallbladder cancer who underwent attempted curative resection from 1999 to 2012 at the University of California, Irvine Medical Center were reviewed. Survival probability was determined using the Kaplan-Meier method. Ten patients underwent laparoscopy, were deemed unresectable, and no further surgical intervention was performed. R0 surgical resection, which included radical portal lymphadenectomy, liver segment IVb/Vresection, with or without bile duct resection, was performed in the remaining 32 patients. N2 nodes were resected if positive on frozen section. Overall survival probability for Stage I to II patients was 100 per cent. Overall survival probability for Stage III patients was 80 per cent (95% confidence interval [CI], 61 to 99%) and 39.3 per cent (95% CI, 28 to 78%) for Stage IV patients. This study demonstrates that 7th edition clinical stage, T stage, and liver involvement are statistically significant predictors of prognosis. These data also demonstrate a benefit to extended resection in patients even with Stage III and IV disease.

AB - Gallbladder cancer is a rare malignancy, which often goes undiagnosed until advanced stages of disease and is associated with poor prognosis. The only potentially curative treatment is surgical resection. This retrospective study aims to investigate the validity of the revised 7th edition American Joint Committee on Cancer staging criteria and determine prognostic factors. Forty-two patients with confirmed gallbladder cancer who underwent attempted curative resection from 1999 to 2012 at the University of California, Irvine Medical Center were reviewed. Survival probability was determined using the Kaplan-Meier method. Ten patients underwent laparoscopy, were deemed unresectable, and no further surgical intervention was performed. R0 surgical resection, which included radical portal lymphadenectomy, liver segment IVb/Vresection, with or without bile duct resection, was performed in the remaining 32 patients. N2 nodes were resected if positive on frozen section. Overall survival probability for Stage I to II patients was 100 per cent. Overall survival probability for Stage III patients was 80 per cent (95% confidence interval [CI], 61 to 99%) and 39.3 per cent (95% CI, 28 to 78%) for Stage IV patients. This study demonstrates that 7th edition clinical stage, T stage, and liver involvement are statistically significant predictors of prognosis. These data also demonstrate a benefit to extended resection in patients even with Stage III and IV disease.

UR - http://www.scopus.com/inward/record.url?scp=84885604029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885604029&partnerID=8YFLogxK

M3 - Article

C2 - 24160796

AN - SCOPUS:84885604029

VL - 79

SP - 1045

EP - 1049

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 10

ER -